189 related articles for article (PubMed ID: 7011748)
1. Receptor depletion in diabetes mellitus: correction with therapy.
Eaton RP; Galagan R; Kaufman E; Allen RC; Russell L; Miller F
Diabetes Care; 1981; 4(2):299-304. PubMed ID: 7011748
[TBL] [Abstract][Full Text] [Related]
2. Insulin receptor defect in diabetic man with chronic renal failure: a comparison of erythrocyte insulin binding in diabetic and nondiabetic patients on maintenance hemodialysis.
Gambhir KK; Nerurkar SG; Cruz IA; Hosten AO
Biochem Med; 1981 Feb; 25(1):62-73. PubMed ID: 7013759
[No Abstract] [Full Text] [Related]
3. Autophosphorylation of insulin receptor in a patient with Werner's syndrome associated with insulin resistant diabetes mellitus.
Shima F; Ishida Y; Hotta K; Hagino H; Hozumi T; Shii K; Baba S; Kazumi T
Endocr J; 1995 Feb; 42(1):107-13. PubMed ID: 7599691
[TBL] [Abstract][Full Text] [Related]
4. [Insulin cell receptors in diabetes caused by pancreatitis].
Frati-Munari AC; Rodríguez-Rodríguez J; Altamirano P
Arch Invest Med (Mex); 1987; 18(2):157-66. PubMed ID: 3310946
[No Abstract] [Full Text] [Related]
5. Erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus.
DePirro R; Fusco A; Lauro R; Testa I; Ferreti F; DeMartinis C
Diabetes; 1980 Feb; 29(2):96-9. PubMed ID: 6986305
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte and monocyte insulin binding in man: a comparative analysis in normal and disease states.
Dons RF; Ryan J; Gorden P; Wachslicht-Rodbard H
Diabetes; 1981 Nov; 30(11):896-902. PubMed ID: 7028544
[No Abstract] [Full Text] [Related]
7. A case of maturity-onset diabetes mellitus resistant to insulin but responsive to tolbutamide.
Rendell M; Slevin D; Meltz G; Simpson J; Barquet A
Ann Intern Med; 1979 Feb; 90(2):195-7. PubMed ID: 443652
[TBL] [Abstract][Full Text] [Related]
8. [Erythrocyte receptors of insulin].
Thomopoulos P; Testa U; Vainchenker W
Journ Annu Diabetol Hotel Dieu; 1982; ():19-30. PubMed ID: 7098247
[No Abstract] [Full Text] [Related]
9. Erythrocyte insulin binding in a family with hereditary motor sensory neuropathy (Charcot-Marie-Tooth) with superimposed insulin-dependent type I diabetes mellitus.
Ivarsson SA; Bjerre I
Diabetes Res; 1989 Jan; 10(1):49-51. PubMed ID: 2667841
[TBL] [Abstract][Full Text] [Related]
10. Insulin binding to erythrocytes in diabetic patients.
Okamoto M; Kuzuya H; Seino Y; Ikeda M; Imura H
Endocrinol Jpn; 1981 Apr; 28(2):169-73. PubMed ID: 7030723
[TBL] [Abstract][Full Text] [Related]
11. [Erythrocyte insulin receptors technics and clinical applications].
Rizkalla SW; Le Bouc Y; Desplanque N; Weissbrodt P; Serog P; Apfelbaum M; Slama G; Tchobroutsky G
Journ Annu Diabetol Hotel Dieu; 1982; ():45-52. PubMed ID: 7047841
[No Abstract] [Full Text] [Related]
12. Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo.
Schernthaner G; Prager R; Punzengruber C; Luger A
Diabetologia; 1985 Mar; 28(3):138-42. PubMed ID: 3888755
[TBL] [Abstract][Full Text] [Related]
13. Erythrocytes: a new cell type for the evaluation of insulin receptor defects in diabetic humans.
Robinson TJ; Archer JA; Gambhir KK; Hollis VW; Carter L; Bradley C
Science; 1979 Jul; 205(4402):200-2. PubMed ID: 451590
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte insulin binding abnormalities in fibro calculous pancreatic diabetes.
Ramachandran A; Susheela L; Mohan V; Kuzali DA; Viswanathan M
Horm Metab Res; 1988 Nov; 20(11):693-7. PubMed ID: 3063650
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
[TBL] [Abstract][Full Text] [Related]
16. Insulin binding to erythrocytes in diabetes mellitus.
Okada Y; Arima T; Okazaki S; Nakata K; Yamabuki T; Nagashima H
Acta Med Okayama; 1981 Oct; 35(4):273-7. PubMed ID: 6457514
[TBL] [Abstract][Full Text] [Related]
17. Insulin binding of erythrocytes in hypoinsulinemic diabetics and its relationship to metabolic states.
Oka Y; Ezaki O; Akanuma Y; Kosaka K
Endocrinol Jpn; 1981 Oct; 28(5):615-22. PubMed ID: 7047154
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of the serum I.R.I. in persons with latent diabetes after endovenous tolbutamide load].
Artenisio AC; Albanese MC; Allegra V; Alibrando S; Caruso A; Sprovieri M; Corsi V
Folia Endocrinol; 1972 Aug; 25(4):300-11. PubMed ID: 4678219
[No Abstract] [Full Text] [Related]
19. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
Lauvaux JP; Mandart G; Heymans G; Ooms HA
Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
[No Abstract] [Full Text] [Related]
20. Therapeutic effect of tolbutamide in non-insulin dependent diabetes mellitus (NIDDM). Relation to beta-cell function.
Damsgaard EM; Faber O; Frøland A; Iversen S
Acta Endocrinol (Copenh); 1982 Jul; 100(3):416-20. PubMed ID: 7051723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
